-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Dizr811fAYlCtO7j67vWDRpexgSNQU8Og61RCJO27MoFIz2ue2i2C73vA6ybFzEg RTGQW/rGCoUz2PQv6vv0eA== 0000930413-09-000858.txt : 20090217 0000930413-09-000858.hdr.sgml : 20090216 20090217165547 ACCESSION NUMBER: 0000930413-09-000858 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20081231 FILED AS OF DATE: 20090217 DATE AS OF CHANGE: 20090217 EFFECTIVENESS DATE: 20090217 FILER: COMPANY DATA: COMPANY CONFORMED NAME: JAY JEFFREY R CENTRAL INDEX KEY: 0001239607 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-12517 FILM NUMBER: 09615028 BUSINESS ADDRESS: STREET 1: WHITNEY & CO. STREET 2: 177 BROAD STREET CITY: STAMFORD STATE: CT ZIP: 06901 BUSINESS PHONE: 203-971-3300 MAIL ADDRESS: STREET 1: GREAT POINT PARTNERS, LLC STREET 2: 2 PICKWICK PLAZA, SUITE 450 CITY: GREENWICH STATE: CT ZIP: 06830 13F-HR 1 c56647_13f-hr.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F COVER PAGE Report for the Calendar Year or Quarter Ended: December 31, 2008 ------------------------ Check here if Amendment [ ]; Amendment Number: ____ This Amendment (Check only one.): [ ] is a restatement. [ ] adds new holdings entries. Institutional Investment Manager Filing this Report: Name: Dr. Jeffrey R. Jay, M.D ----------------------------------------------------- Address: 165 Mason Street - 3rd Floor ----------------------------------------------------- Greenwich, CT 06830 ----------------------------------------------------- 13F File Number: 028-12517 --------- The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form. Person Signing this Report on Behalf of Reporting Manager: Name: ------------------------------------------------------------------------ Title: ------------------------------------------------------------------------ Phone: ------------------------------------------------------------------------ Signature, Place, and Date of Signing: /s/ Dr. Jeffrey R. Jay, M.D. Greenwich, CT February 17, 2009 - ---------------------------- ----------------- -------------------- [Signature] [City, State] [Date] Report Type (Check only one.): [X] 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report.) [ ] 13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).) [ ] 13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s).) List of Other Managers Reporting for this Manager: 13F File Number Name 28-____________ ___________________________________ FORM 13F SUMMARY PAGE Report Summary: Number of Other Included Managers: 2 -------------- Form 13F Information Table Entry Total: 43 -------------- Form 13F Information Table Value Total: $ 138,481 -------------- (thousands) List of Other Included Managers: Mr. David Kroin Great Point Partners, LLC Provide a numbered list of the name(s) and 13F file number(s) of all institutional investment managers with respect to which this report is filed, other than the manager filing this report. No. 13F File Number Name 1 028-13262 Mr. David Kroin 2 028-11743 Great Point Partners, LLC
VOTING AUTHORITY NAME OF ISSUER TITLE OF CUSIP MARKET SHARE/PRN SHARE/ PUT/ INVESTMENT OTHER SOLE SHARED NONE CLASS VALUE (USD) AMOUNT PRN CALL DISCRETION MANAGERS AMAG PHARMACEUTICALS, INC. COM 00163U106 5,000 150 SH Shared-Defined 1, 2 150 0 NONE CALL/AMAG(AVMAM) @ 65 EXP 01/17/2009 CALL 00163U106 1,000 50 SH CALL Shared-Defined 1, 2 50 0 NONE CALL/AMAG(YJWAR) @ 90 EXP 01/16/2010 CALL 00163U106 31,000 224 SH CALL Shared-Defined 1, 2 224 0 NONE CALL/AMAG(YJWAM) @ 65 EXP 01/16/2010 CALL 00163U106 517,000 1,100 SH CALL Shared-Defined 1, 2 1,100 0 NONE ATS MEDICAL INC COM 002083103 2,641,000 950,000 SH Shared-Defined 1, 2 950,000 0 NONE ABIOMED INC COM 003654100 28,159,000 1,714,935 SH Shared-Defined 1, 2 1,714,935 0 NONE ADOLOR CORP COM 00724X102 2,274,000 1,369,619 SH Shared-Defined 1, 2 1,369,619 0 NONE ANADYS PHARMACEUTICALS, INC. COM 03252Q408 3,349,000 2,136,036 SH Shared-Defined 1, 2 2,136,036 0 NONE ANGIODYNAMICS, INC. COM 03475V101 6,982,000 510,000 SH Shared-Defined 1, 2 510,000 0 NONE APPLE, INC. COM 037833100 9,000 100 SH Shared-Defined 1, 2 100 0 NONE AVALON PHARMACEUTICALS INC COM 05346P106 221,000 760,000 SH Shared-Defined 1, 2 760,000 0 NONE BIOMARIN PHARMACEUTICAL INC COM 09061G101 7,832,000 440,000 SH Shared-Defined 1, 2 440,000 0 NONE CELGENE CORPORATION COM 151020104 8,845,000 160,000 SH Shared-Defined 1, 2 160,000 0 NONE CEPHALON INC COM 156708109 6,934,000 90,000 SH Shared-Defined 1, 2 90,000 0 NONE CONMED CORP COM 207410101 239,000 10,000 SH Shared-Defined 1, 2 10,000 0 NONE CALL/CYPB(QGYCB) @ 10 EXP 03/21/2009 CALL 232674507 146,000 1,500 SH CALL Shared-Defined 1, 2 1,500 0 NONE DEXCOM, INC. COM 252131107 219,000 79,500 SH Shared-Defined 1, 2 79,500 0 NONE FIVE STAR QUALITY CARE INC COM 33832D106 304,000 198,720 SH Shared-Defined 1, 2 198,720 0 NONE GENTIUM SPA SPONSORED ADR COM 37250B104 251,000 425,532 SH Shared-Defined 1, 2 425,532 0 NONE HOLOGIC INCORPORATED COM 436440101 3,921,000 300,000 SH Shared-Defined 1, 2 300,000 0 NONE CALL/ISPH(JPUAU) @ 7.5 EXP 01/17/2009 CALL 457733103 13,000 5,000 SH CALL Shared-Defined 1, 2 5,000 0 NONE INTUITIVE SURGICAL, INC. COM 46120E602 1,905,000 15,000 SH 15,000 0 NONE KERYX BIOPHARMACEUTICALS INC COM 492515101 3,000 15,000 SH 15,000 0 NONE LUMINEX CORP COM 55027E102 267,000 12,500 SH 12,500 MAP PHARMACEUTICALS, INC. COM 56509R108 14,000 2,000 SH Shared-Defined 1, 2 2,000 0 NONE MEMORY PHARMACEUTICALS CORP COM 58606R403 5,340,000 8,825,760 SH Shared-Defined 1, 2 8,825,760 0 NONE MERIT MEDICAL SYS INC COM 589889104 269,000 15,000 SH Shared-Defined 1, 2 15,000 0 NONE NOVAMED INC COM 66986W108 3,131,000 904,908 SH Shared-Defined 1, 2 904,908 0 NONE NXSTAGE MEDICAL INC COM 67072V103 2,003,000 750,000 SH Shared-Defined 1, 2 750,000 0 NONE QUIDEL CORP COM 74838J101 261,000 20,000 SH Shared-Defined 1, 2 20,000 0 NONE RTI BIOLOGICS, INC. COM 74975N105 2,553,000 925,000 SH Shared-Defined 1, 2 925,000 0 NONE ST JUDE MEDICAL INC COM 790849103 5,768,000 175,000 SH Shared-Defined 1, 2 175,000 0 NONE SHIRE LIMITED SPONSORED ADR COM 82481R106 4,478,000 100,000 SH Shared-Defined 1, 2 100,000 0 NONE STERIS CORP COM 859152100 239,000 10,000 SH Shared-Defined 1, 2 10,000 0 NONE THERMO FISHER SCIENTIFIC INC COM 883556102 1,704,000 50,000 SH Shared-Defined 1, 2 50,000 0 NONE TRANSITION THERAPEUTICS INC. COM 893716209 7,194,000 1,859,000 SH Shared-Defined 1, 2 1,859,000 0 NONE UNITED THERAPEUTICS CORP COM 91307C102 9,383,000 150,000 SH Shared-Defined 1, 2 150,000 0 NONE CALL/UTHR(WUMAU) @ 130 EXP 01/16/2010 CALL 91307C102 83,000 340 SH CALL Shared-Defined 1, 2 340 0 NONE WELLCARE HEALTH PLANS INC COM 94946T106 103,000 8,000 SH Shared-Defined 1, 2 8,000 0 NONE ZIMMER HLDGS INC COM 98956P102 7,276,000 180,000 SH Shared-Defined 1, 2 180,000 0 NONE COVIDIEN LTD. COM G2552X108 1,812,000 50,000 SH Shared-Defined 1, 2 50,000 0 NONE ORTHOFIX INTERNATIONAL COM N6748L102 3,066,000 200,000 SH Shared-Defined 1, 2 200,000 0 NONE Biodel, Inc. COM 09064M105 $8,736,601.86 1,812,573 SH Shared-Defined 1 1,812,573 0 NONE ---------- 25,232,547 ==========
-----END PRIVACY-ENHANCED MESSAGE-----